IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Dishman Establishes Economic Zones in India

11:46 AM MDT | September 12, 2008 | Deepti Ramesh

Dishman Pharmaceuticals & Chemicals (Ahmedabad, India) says it will invest a combined sum of about $125 million in a pharmaceutical and chemical special economic zone (SEZ) that it is establishing at Bavla, India and in an engineering SEZ it is planning to establish at Bavla. Dishman says it is also building Asia’s largest facility to manufacture cancer drugs and other high-potency drugs at its existing plant at Bavla, which is separate from the SEZ’s. The company manufactures active pharmaceutical ingredients (API), API intermediates, quaternary...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa